| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BC034221G |
| P698 | PubMed publication ID | 15025524 |
| P50 | author | Patrick L Iversen | Q62478653 |
| P2093 | author name string | Hong M Moulton | |
| Michelle H Nelson | |||
| Muralimohan T Reddy | |||
| Susie A Hatlevig | |||
| P433 | issue | 2 | |
| P304 | page(s) | 290-299 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Bioconjugate Chemistry | Q2343023 |
| P1476 | title | Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides | |
| P478 | volume | 15 |
| Q47742760 | (R-X-R)4 -Motif Peptides Containing Conformationally Constrained Cyclohexane-Derived Spacers: Effect on Cellular Uptake. |
| Q57464951 | A cationic morpholino antisense oligomer conjugate: synthesis, cellular uptake and inhibition of Gli1 in the hedgehog signalling pathway |
| Q38898494 | A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus. |
| Q56115525 | Amphipathic trans-acting phosphorothioate DNA elements mediate the delivery of uncharged nucleic acid sequences in mammalian cells |
| Q42143713 | An amphipathic trans-acting phosphorothioate DNA element delivers uncharged PNA and PMO nucleic acid sequences in mammalian cells |
| Q27480935 | Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries |
| Q34881433 | Antisense oligonucleotide inhibition of hepatitis C virus genotype 4 replication in HepG2 cells |
| Q45858623 | Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. |
| Q33761035 | Antiviral and neuroprotective role of octaguanidinium dendrimer-conjugated morpholino oligomers in Japanese encephalitis |
| Q24682873 | Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models |
| Q45099190 | Arginine-rich cell-penetrating peptides with uncharged antisense oligomers |
| Q40182984 | Assessing the delivery efficacy and internalization route of cell-penetrating peptides |
| Q37043515 | Bioconjugation of oligonucleotides for treating liver fibrosis |
| Q27486045 | Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus |
| Q29994527 | Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond |
| Q37013966 | Cell penetrating peptide conjugates of steric block oligonucleotides |
| Q38974187 | Cell-Penetrating Peptides for Antiviral Drug Development |
| Q55638503 | Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics. |
| Q38974236 | Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems. |
| Q24814987 | Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells |
| Q27481059 | Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity |
| Q38056000 | Chemical architecture and applications of nucleic acid derivatives containing 1,2,3-triazole functionalities synthesized via click chemistry. |
| Q37190830 | Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection |
| Q39470764 | Co-operative membrane disruption between cell-penetrating peptide and cargo: implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8. |
| Q45378226 | Curing of HeLa cells persistently infected with equine arteritis virus by a peptide-conjugated morpholino oligomer |
| Q34994545 | Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. |
| Q47440527 | Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy |
| Q36972120 | Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies. |
| Q38369597 | Delivery of therapeutic oligonucleotides with cell penetrating peptides. |
| Q36108360 | Deregulation of FoxM1b leads to tumour metastasis |
| Q35270489 | Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors |
| Q36432717 | Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections |
| Q57094800 | Dynamic Nuclear Polarization Nuclear Magnetic Resonance in Human Cells Using Fluorescent Polarizing Agents |
| Q33619608 | Endocytosis and intracellular trafficking properties of transferrin-conjugated block copolypeptide vesicles |
| Q36169056 | Epigenetic manipulation of gene expression: a toolkit for cell biologists |
| Q93006864 | Evaluation of Amphiphilic Peptide Modified Antisense Morpholino Oligonucleotides In Vitro and in Dystrophic mdx Mice |
| Q39120926 | Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice. |
| Q46976778 | Impact of the guanidinium group on hybridization and cellular uptake of cationic oligonucleotides |
| Q39021362 | Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier |
| Q39726013 | Inhibition of Japanese encephalitis virus replication in cultured cells and mice by a peptide-conjugated morpholino oligomer. |
| Q27490424 | Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice |
| Q27486413 | Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers |
| Q39321221 | Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site. |
| Q24520621 | Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers |
| Q40363892 | Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure |
| Q27469445 | Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication |
| Q40087750 | Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers. |
| Q40388025 | Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers. |
| Q30396910 | Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2. |
| Q45388172 | Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers. |
| Q24675029 | Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers |
| Q36989997 | Inhibition of norovirus replication by morpholino oligomers targeting the 5'-end of the genome. |
| Q27486093 | Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers |
| Q38323658 | Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers |
| Q33577349 | Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers |
| Q64215199 | Knockdown of phosphoethanolamine transmethylation enzymes decreases viability of Haemonchus contortus |
| Q55145552 | Machine Learning To Predict Cell-Penetrating Peptides for Antisense Delivery. |
| Q37193000 | Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides |
| Q36212957 | Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections |
| Q51741167 | Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity. |
| Q37393524 | Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization. |
| Q35439476 | Parallel synthesis of cell-penetrating peptide conjugates of PMO toward exon skipping enhancement in Duchenne muscular dystrophy. |
| Q36297919 | Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis. |
| Q93138367 | Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases |
| Q40062922 | Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication |
| Q37347451 | Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems |
| Q52685816 | Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides. |
| Q27487857 | Recent Developments in Peptide-Based Nucleic Acid Delivery |
| Q30859046 | Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis |
| Q24539118 | Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome |
| Q40448608 | Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages. |
| Q92130410 | Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease |
| Q27009581 | Splicing therapy for neuromuscular disease |
| Q38311521 | Suppression of porcine reproductive and respiratory syndrome virus replication by morpholino antisense oligomers. |
| Q37165327 | Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. |
| Q39384935 | Synthesis and in vitro inhibition properties of oligonucleotide conjugates carrying amphipathic proline-rich peptide derivatives of the sweet arrow peptide (SAP). |
| Q24793327 | Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides |
| Q40175397 | Targeted gene knockdown validates the essential role of lactate dehydrogenase in Cryptosporidium parvum |
| Q42809859 | Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides |
| Q42807094 | Transduction of peptides and proteins into live cells by cell penetrating peptides |
| Q34787775 | Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus. |
| Q38074834 | Update on the treatment of Duchenne muscular dystrophy |
| Q38288902 | Using Morpholinos to Control Gene Expression |
| Q53465855 | Using Morpholinos to control gene expression. |
| Q53481883 | Using morpholinos to control gene expression. |
| Q34509643 | VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice |
| Q46783979 | Vesicular disruption of lysosomal targeting organometallic polyarginine bioconjugates |
| Q36373107 | siRNA-based approaches in cancer therapy |
Search more.